Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic LeukemiaKathryn G. Roberts, Timothy P. Hughes, Jing Ma et al.|New England Journal of Medicine|2014Cited by 1.4k
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemiaZhaohui Gu, Williams E. Evans, Michelle L. Churchman et al.|Nature Genetics|2019Cited by 616
The genomic landscape of pediatric acute lymphoblastic leukemiaSamuel W. Brady, Richard C. Harvey, Kathryn G. Roberts et al.|Nature Genetics|2022Cited by 394
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology GroupShalini C. Reshmi, Stephen P. Hunger, Richard C. Harvey et al.|Blood|2017Cited by 305
Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical SpectrumMarialetizia Motta, Marco Tartaglia, Luca Pannone et al.|The American Journal of Human Genetics|2020Cited by 95